XSHE
002942
Market cap356mUSD
May 30, Last price
16.75CNY
1D
-1.06%
1Q
11.15%
IPO
-4.07%
Name
Zhejiang XinNong Chemical Co Ltd
Chart & Performance
Profile
Zhejiang XinNong Chemical Co.,Ltd. researches, develops, produces, and markets pesticides and pharmaceutical intermediates in China. It also exports its products to Southeast Asia, Europe, the United States, Australia, and Africa. The company was founded in 1981 and is based in Hangzhou, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 821,032 -34.22% | 1,248,167 7.36% | |||||||
Cost of revenue | 754,258 | 1,075,091 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 66,774 | 173,076 | |||||||
NOPBT Margin | 8.13% | 13.87% | |||||||
Operating Taxes | 8,625 | ||||||||
Tax Rate | 4.98% | ||||||||
NOPAT | 66,774 | 164,451 | |||||||
Net income | 101,397 -26.46% | ||||||||
Dividends | (38,302) | (76,605) | |||||||
Dividend yield | 1.31% | 3.09% | |||||||
Proceeds from repurchase of equity | 1,026 | ||||||||
BB yield | -0.04% | ||||||||
Debt | |||||||||
Debt current | 1,416 | ||||||||
Long-term debt | 605 | 2,841 | |||||||
Deferred revenue | 6,412 | 6,454 | |||||||
Other long-term liabilities | 1 | ||||||||
Net debt | (231,291) | (513,510) | |||||||
Cash flow | |||||||||
Cash from operating activities | 90,476 | 138,072 | |||||||
CAPEX | (71,408) | ||||||||
Cash from investing activities | |||||||||
Cash from financing activities | (39,828) | ||||||||
FCF | 67,074 | 129,500 | |||||||
Balance | |||||||||
Cash | 475,928 | 517,767 | |||||||
Long term investments | (244,032) | ||||||||
Excess cash | 190,844 | 455,358 | |||||||
Stockholders' equity | 664,510 | 895,724 | |||||||
Invested Capital | 937,712 | 721,435 | |||||||
ROIC | 8.05% | 23.85% | |||||||
ROCE | 5.82% | 14.51% | |||||||
EV | |||||||||
Common stock shares outstanding | 149,260 | 153,210 | |||||||
Price | 19.65 21.30% | 16.20 -10.10% | |||||||
Market cap | 2,932,967 18.17% | 2,482,001 -10.24% | |||||||
EV | 2,701,676 | 1,968,491 | |||||||
EBITDA | 118,782 | 219,795 | |||||||
EV/EBITDA | 22.74 | 8.96 | |||||||
Interest | 497 | 136 | |||||||
Interest/NOPBT | 0.74% | 0.08% |